Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

FTC’s Shire Appeal Denied in Fight Over Citizen Petitions

  • Post author:Sam
  • Post published:February 27, 2019
  • Post category:Drug Industry Daily

The U.S. Court of Appeals for the Third Circuit upheld a Delaware federal district court’s decision to throw out an FTC lawsuit that sought to curb alleged misuse of citizen…

Continue ReadingFTC’s Shire Appeal Denied in Fight Over Citizen Petitions

Novartis Considers Appealing $1.5 Million Whistleblower Verdict

  • Post author:Sam
  • Post published:February 27, 2019
  • Post category:Drug Industry Daily

Novartis is hinting that it will appeal a New Jersey jury’s verdict awarding $1.5 million to a former executive who alleged that the company created a bogus drug study to…

Continue ReadingNovartis Considers Appealing $1.5 Million Whistleblower Verdict

BSI Warns Devicemakers to Migrate CE Certificates Before Brexit Deadline

  • Post author:Sam
  • Post published:February 8, 2019
  • Post category:The GMP Letter

With a looming hard Brexit exit less than 60 days away, BSI is warning devicemakers that their CE certificates in the UK could become invalid if the UK and EU…

Continue ReadingBSI Warns Devicemakers to Migrate CE Certificates Before Brexit Deadline

FDA Cites Six Firms for GMP, Other Issues

  • Post author:Sam
  • Post published:February 8, 2019
  • Post category:The GMP Letter

The FDA rapped six device facilities for a variety of deficiencies identified during inspections, including problems with CAPAs and medical device reporting. Source: The GMP Letter

Continue ReadingFDA Cites Six Firms for GMP, Other Issues

China Introduces Routine Overseas Device Inspections

  • Post author:Sam
  • Post published:February 8, 2019
  • Post category:The GMP Letter

China’s National Medical Products Administration is increasing its scrutiny of foreign manufacturers and will begin routine, risk-based inspections of foreign facilities to confirm they are in compliance with Chinese regulations.…

Continue ReadingChina Introduces Routine Overseas Device Inspections

HSCC Introduces Plan for Cybersecurity ‘By Design’

  • Post author:Sam
  • Post published:February 8, 2019
  • Post category:The GMP Letter

The Healthcare and Public Health Sector Coordinating Council (HSCC) has developed a new guide for managing the security of medical devices. Source: The GMP Letter

Continue ReadingHSCC Introduces Plan for Cybersecurity ‘By Design’

CDRH Seeks Stakeholder Input on 2019 Guidance Priorities

  • Post author:Sam
  • Post published:February 8, 2019
  • Post category:The GMP Letter

FDA’s Center for Devices and Radiological Health called for feedback from stakeholders on its priorities for developing guidance for the year ahead. Source: The GMP Letter

Continue ReadingCDRH Seeks Stakeholder Input on 2019 Guidance Priorities

Health Canada Maps Out Action Plan to Improve Device Safety, Quality

  • Post author:Sam
  • Post published:February 8, 2019
  • Post category:The GMP Letter

Health Canada released a three-part action plan aimed at improving how devices get on the market, strengthening monitoring and providing more information to consumers about the devices they use. Source:…

Continue ReadingHealth Canada Maps Out Action Plan to Improve Device Safety, Quality

Notified Bodies Warn of Future Bottlenecks in Implementing New Device Regs

  • Post author:Sam
  • Post published:February 8, 2019
  • Post category:The GMP Letter

The European Association for Medical Devices of Notified Bodies (Team-NB) is sounding alarms over the shortage of notified bodies to conduct audits and certify devicemakers in time to comply with…

Continue ReadingNotified Bodies Warn of Future Bottlenecks in Implementing New Device Regs

EMA Considers Electronic Product Information Standard for Drugs

  • Post author:Sam
  • Post published:February 5, 2019
  • Post category:Drug GMP Report

The European Medicines Agency began a six-month public consultation Thursday for draft principles on a common EU standard for human drug electronic product information. Source: Drug GMP Report

Continue ReadingEMA Considers Electronic Product Information Standard for Drugs
  • Go to the previous page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.